Riskpilot← Back to searchSign inGet full accessBIOCONTROL AS
ASActiveOrg 959837090Gautestadveien 75, 1894 RakkestadManufacture of agricultural and forestry machinery · NACE 2830Est. 199124 employees
Revenue 2024
NOK 53M
-5% vs 2023
EBITDA margin
2.1%
-76% vs 2023
Equity ratio
63.7%
Financial strength
Net profit 2024
NOK 942K
-73% vs 2023
| Revenue | NOK 53M | -5% |
| EBITDA | NOK 1,1M | -76% |
| Net profit | NOK 942K | -73% |
| Total assets | NOK 44,8M | +15% |
| Equity | NOK 28,5M | +3% |
| Employees | 24 | — |
Legal name
BIOCONTROL AS
Org number
959837090
Legal form
Aksjeselskap
NACE code
2830 · Manufacture of agricultural and forestry machinery
Founded
22. januar 1991
Share capital
NOK 2 576 800
Employees
24 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Address
Gautestadveien 75, 1894 Rakkestad
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 36 739 | 47 969 | 60 648 | 55 762 | 52 976 |
| Staff expenses | −7 929 | −9 301 | −10 779 | −13 266 | −13 851 |
| EBITDA | 4 949 | 4 534 | 8 358 | 4 710 | 1 130 |
| Depreciation & amort. | −540 | −779 | −992 | −997 | −950 |
| EBIT | 4 409 | 3 755 | 7 366 | 3 713 | 180 |
| Net financials | 2 333 | −63 | 582 | 742 | 941 |
| Profit before tax | 6 742 | 3 693 | 7 948 | 4 455 | 1 121 |
| Tax | 835 | 812 | 1 749 | 983 | 179 |
| Net profit | 5 906 | 2 880 | 6 200 | 3 472 | 942 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 35 974 | 38 629 | 37 069 | 38 987 | 44 812 |
| Equity | 22 443 | 25 323 | 26 323 | 27 581 | 28 523 |
| Long-term debt | 0 | 0 | 0 | 143 | 673 |
| Short-term debt | 13 531 | 13 306 | 10 746 | 11 262 | 15 616 |
| Total debt | 13 531 | 13 306 | 10 746 | 11 405 | 16 289 |
EBITDA margin
2.1%
This company
15.8%
Market median
-87% vs market
20202024
Equity ratio
63.7%
This company
38.2%
Market median
+67% vs market
20202024
Return on equity
3.3%
This company
18.4%
Market median
-82% vs market
20202024
Net profit margin
1.8%
This company
8.1%
Market median
-78% vs market
20202024
Asset turnover
1.18×
This company
1.12×
Market median
+5% vs market
20202024
Debt / equity
0.57×
This company
0.62×
Market median
+8% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SM Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (1) | ||
BH Accountant | Accountant | 2017 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 90.1% | 90.1% | 2024 | |
| Company | 9.9% | 9.9% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Oredalen As
BIOCONTROL AS Board members of BIOCONTROL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bente Holm Borgen | Accountant | 0 companies |
| Signe Marie Jahren Viaud | Chief Executive Officer | 0 companies |
| Vidar Mellegård | Board of Directors | 0 companies |
| Even Jahren | Chairman | 0 companies |